🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Uro applicants! Want to know our programs superpower? Spoiler alert: it’s our residents! They are hosting a virtual mixer this Monday August 26th at 6 PM central. Email [email protected] from your .edu email for the link.

Excited to have our faculty J. Nicholas Sreshta, MD, FACS Stephen B. Williams, MD, MBA, MS, FACHE chairing, presenting, moderating at South Central Section of the AUA #SCSC2024 annual meeting in Colorado Springs. Look forward to resident presentations including Ali Nasrallah, MD! 👍💪💫 UTMB Health UTMBPresident UTMB Provost's Office Amer. Urol. Assn.

#BladderCancer recurrence analysis in #veterans and outcomes #BRAVO: White light vs blue light cystoscopy outcomes among #NMIBC patients in an equal access setting. Presentation by Ali Nasrallah, MD UTMBUrology. #SCSAUA24 written coverage by Zach Klaassen Georgia Cancer Center >

#BRAVO trial highlights improved detection reduces #BladderCancer recurrence. Ali Nasrallah, MD UTMBUrology and Zach Klaassen Georgia Cancer Center discuss the real-world impact of blue light cystoscopy versus white light cystoscopy in non-muscle invasive bladder cancer patients within

#SCSAUA Presenting our findings on the oncologic impact of Blue Light Cystoscopy in an equal access setting! South Central Section of the AUA UTMBUrology Stephen B. Williams, MD, MBA, MS, FACHE

#BRAVO trial highlights improved detection reduces #BladderCancer recurrence. Ali Nasrallah, MD UTMBUrology and Zach Klaassen Georgia Cancer Center discuss the real-world impact of blue light cystoscopy versus white light cystoscopy in non-muscle invasive bladder cancer patients within

Excited to share the release of a new book on bladder cancer that I had the pleasure of editing together with Margaret Knowles, featuring contributions from multiple expert authors! “Biology of Bladder Cancer: From Molecular Insights to Clinical Strategies” provides a

Lars Dyrskjøt Aarhus Universitet Dept. of Molecular Medicine Congrats to the outstanding team and thanks for including me on this important addition to understanding the rapid evolving field of bladder cancer. Special thanks Ali Nasrallah, MD UTMBUrology for his work on our chapter and future Society of Urologic Oncology fellow applicant! 👍🎉

#BRAVO trial highlights improved detection reduces #BladderCancer recurrence. Ali Nasrallah, MD UTMBUrology and Zach Klaassen Georgia Cancer Center discuss the real-world impact of blue light cystoscopy versus white light cystoscopy in non-muscle invasive bladder cancer patients within

Match results are in, and we are excited to welcome Anthony Fadel and Ekam Deol to the UTMBUrology family!

👏 The BRAVO study, led by Ali Nasrallah, MD and Dr. Sanjay Das, MD MPH, has provided new insight into the efficacy of blue light cystoscopy over white light cystoscopy on the oncologic outcomes of patients with #NMIBC: buff.ly/HgdRky1 👉 Research has shown that BLC can improve

📰 "Oncologic Outcomes of Blue Light Cystoscopy in an Equal Access Setting: Results of the BRAVO Study." Read the full article here! ➡️ bit.ly/42C04wn #Urology

Just wrapped up our second UTMBUrology Male Stress Urinary Incontinence Masterclass—an incredible day of learning, teaching, and sharing advanced tips on male sling and AUS, using highly specialized hybrid animal models. Grateful for Boston Scientific Urology for the support. ICS

Wonderful session today, thank you Bilal Farhan, MD FACS for organizing this!